Fintel reports that on August 16, 2023, UBS upgraded their outlook for Aemetis (NASDAQ:AMTX) from Neutral to Buy.

Analyst Price Forecast Suggests 75.05% Upside

As of August 2, 2023, the average one-year price target for Aemetis is 10.78. The forecasts range from a low of 2.52 to a high of $29.40. The average price target represents an increase of 75.05% from its latest reported closing price of 6.16.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Aemetis is 374MM, an increase of 101.29%. The projected annual non-GAAP EPS is -0.37.

What is the Fund Sentiment?

There are 166 funds or institutions reporting positions in Aemetis. This is a decrease of 7 owner(s) or 4.05% in the last quarter. Average portfolio weight of all funds dedicated to AMTX is 0.01%, an increase of 8.41%. Total shares owned by institutions decreased in the last three months by 16.49% to 15,132K shares. The put/call ratio of AMTX is 0.47, indicating a bullish outlook.

What are Other Shareholders Doing?

Grantham, Mayo, Van Otterloo & Co. holds 2,101K shares representing 5.41% ownership of the company. In it’s prior filing, the firm reported owning 2,137K shares, representing a decrease of 1.68%. The firm increased its portfolio allocation in AMTX by 182.80% over the last quarter.

Encompass Capital Advisors holds 1,808K shares representing 4.65% ownership of the company. In it’s prior filing, the firm reported owning 1,811K shares, representing a decrease of 0.18%. The firm increased its portfolio allocation in AMTX by 273.85% over the last quarter.

Alliancebernstein holds 1,254K shares representing 3.23% ownership of the company. In it’s prior filing, the firm reported owning 1,718K shares, representing a decrease of 36.95%. The firm decreased its portfolio allocation in AMTX by 59.27% over the last quarter.

VTSMX – Vanguard Total Stock Market Index Fund Investor Shares holds 1,112K shares representing 2.86% ownership of the company. In it’s prior filing, the firm reported owning 924K shares, representing an increase of 16.90%. The firm decreased its portfolio allocation in AMTX by 34.90% over the last quarter.

GOFIX – GMO Resources Fund Class III holds 765K shares representing 1.97% ownership of the company. No change in the last quarter.

Aemetis Background Information
(This description is provided by the company.)

Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and bioproducts company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. Founded in 2006, Aemetis has completed Phase 1 and is expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas (RNG). Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis also owns and operates a 50 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing the Carbon Zero biorefinery in Riverbank, California to convert renewable hydrogen from waste orchard wood and renewable electricity from solar and hydroelectric sources combined with non-edible oils into renewable jet fuel and renewable diesel, while pre-extracting cellulosic sugars for use by the Keyes ethanol plant to produce cellulosic ethanol. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and bioproducts.

This article originally appeared on Fintel

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.